“the-medicines-company” Archives

in
Entry Author Date Location
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
Blackstone Pays Alnylam $1B to Grab a Stake in RNAi Drug Inclisiran 04/13/20 Boston
Melinta’s Chapter 11 Auction Draws No Bids, Deerfield to Get Assets 03/04/20 New York
Esperion’s FDA-Approved Cholesterol Drug Priced Even Lower Than Expected 02/24/20 Detroit Ann Arbor
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B 11/25/19 New York
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More 10/26/18 National
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections 10/22/18 San Diego
Boston VC Fundraising News: OpenView, CRV, Material Impact 05/14/18 Boston
In Venture Reinvention, Versant Sees Gains Amid Biotech Boom Times 04/29/15 National
Medicines Buys ProFibrix, Led by Former Zymonite, for $90M 08/05/13 Seattle
Domain Associates, Regado Bet Big on Heart Drug 05/09/13 National
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
East Coast Life Sciences Roundup: Biogen Idec, Celgene, Alnylam, More 02/08/13 Boston
Alnylam Gets $25M From Medicines Co. for Cholesterol Drug 02/04/13 Boston
Athenahealth, iRobot, PerkinElmer, & More in Boston Life Sciences News 09/14/12 Boston
Annovation, Agrivida, FashionPlaytes, & More Names from the Boston Deals Roundup 09/12/12 Boston
Annovation BioPharma Secures $8,000,000 Series A Funding 09/11/12 Boston
Annovation Adds $8M to Develop Safer, More Precise Anesthesia 09/10/12 Boston
Would Longer Drug Patents Really Lead to Lower Drug Prices? 09/05/12 Seattle
Pacira Wins FDA Approval of Pain Drug, Cushioning Pain of 3Q Loss 10/31/11 New York
Four Big Cardiovascular Trends to Watch at this Week’s Medical Device Gathering—TCT 2010 09/20/10 San Francisco
Stealthy Mercator, Founded by Biogen Idec Veterans, Raises $2M to Attack Cancer 08/11/10 Boston
$55M for Boston-Power, Sequenom Plows Ahead with Exact Sciences Takeover Attempt, Nuance Announces $175M Stock Sale, & More Boston-Area Deals News 01/16/09 Boston
Cubist and Alnylam Tackle RSV, Exact Sciences Fends Off Sequenom, An FDA Panel Backs GTC Biotherapeutics’ Goat-Milk Drug, & More Boston-Area Life Sciences News 01/14/09 Boston
Targanta Gets $42M Buyout Offer From NJ Drug Firm 01/13/09 Boston
Page 1 of 1